Literature DB >> 7421947

Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies.

R R Lenke, H L Levy.   

Abstract

Since many women with phenylketonuria (PKU) will have children of their own, we were interested in ascertaining the effect of maternal PKU and hyperphenylalaninemia on the offspring of such women. We reviewed the literature on this subject and obtained additional unpublished data through an international survey. Data were collected on 524 pregnancies in 155 women; in 34 pregnancies a low-phenylalanine diet was begun after or shortly before pregnancy was established. Among untreated pregnancies, the frequencies of mental retardation, microcephaly, and congenital heart disease were greatly increased over those in the normal population, and these increases correlated with the mother's blood levels of phenylalanine. Ninety-five per cent of mothers with blood phenylalanine concentrations of 20 mg per deciliter or higher had at least one mentally retarded child. Bias introduced by case-finding methods cannot explain these results. It is not clear from our review whether dietary treatment begun after conception is helpful, but treatment begun before conception should be evaluated.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7421947     DOI: 10.1056/NEJM198011203032104

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  122 in total

1.  Successful pregnancy outcome in atypical hyperglycinaemia.

Authors:  C J Ellaway; H Mundy; P J Lee
Journal:  J Inherit Metab Dis       Date:  2001-10       Impact factor: 4.982

2.  Maternal phenylketonuria: low phenylalaninemia might increase the risk of intra uterine growth retardation.

Authors:  Raphaël Teissier; Emmanuel Nowak; Murielle Assoun; Karine Mention; Aline Cano; Alain Fouilhoux; François Feillet; Hélène Ogier; Emmanuel Oger; Loïc de Parscau
Journal:  J Inherit Metab Dis       Date:  2012-06-05       Impact factor: 4.982

3.  The Resource Mothers Program for Maternal Phenylketonuria.

Authors:  P S St James; E Shapiro; S E Waisbren
Journal:  Am J Public Health       Date:  1999-05       Impact factor: 9.308

Review 4.  Indications for fetal echocardiography.

Authors:  M Small; J A Copel
Journal:  Pediatr Cardiol       Date:  2004 May-Jun       Impact factor: 1.655

Review 5.  Undiagnosed phenylketonuria in adult women: a hidden public health problem.

Authors:  W B Hanley; J T Clarke; W E Schoonheyt
Journal:  CMAJ       Date:  1990-09-15       Impact factor: 8.262

Review 6.  Phenylketonuria: old disease, new approach to treatment.

Authors:  H L Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

7.  Expanded newborn screening: reducing harm, assessing benefit.

Authors:  Bridget Wilcken
Journal:  J Inherit Metab Dis       Date:  2010-05-04       Impact factor: 4.982

8.  Maternal phenylketonuria pregnancy outcome: a preliminary report of facial dysmorphology and major malformations.

Authors:  B Rouse; L Lockhart; R Matalon; C Azen; R Koch; W Hanley; H Levy; F dela Cruz; E Friedman
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

9.  Maternal phenylketonuria: comparison of two treated full term pregnancies.

Authors:  R P Soeters; R C Sengers; P W van Dongen; J M Trijbels; T K Eskes
Journal:  Eur J Pediatr       Date:  1986-08       Impact factor: 3.183

10.  Maternal phenylketonuria in Turkey: outcomes of 71 pregnancies and issues in management.

Authors:  Yılmaz Yıldız; Hatice Serap Sivri
Journal:  Eur J Pediatr       Date:  2019-05-03       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.